Our biomarker panel for determining the presence and severity of osteoarthritis is now being tested clinically in dogs and people. Since our initial publication of this work, interest in licensing this technology for commercial use in human and veterinary hospital and clinics has surged. We are currently working with companies to complete licensing of the technology with the University of Missouri in pursuit of applying this to the real world in order to improve diagnosis and treatment of arthritis for everyone.
Related News
